MIDDLEWAY SURGERY
MIDDLEWAY, ST. BLAZEY, PAR
Stroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 9 | 2005 | 74 | 82 | 90.2% | |
| STROKE 9 | 2006 | 85 | 92 | 92.4% | |
| Stroke 12 | 2007 | 103 | 110 | 93.6% | |
| Stroke 12 | 2008 | 121 | 125 | 96.8% | |
| Stroke 12 | 2009 | 129 | 134 | 96.3% | |
| Stroke 12 | 2010 | 121 | 127 | 95.3% | |
| STROKE 12 | 2011 | 130 | 138 | 94.2% | |
| STROKE 12 | 2012 | 123 | 136 | 90.4% | |
| STROKE 12 | 2013 | 125 | 129 | 96.9% | |
| STIA007 | 2014 | 118 | 121 | 97.5% | |
| STIA007 | 2015 | 127 | 129 | 98.4% | |
| STIA007 | 2016 | 126 | 129 | 97.7% | |
| STIA007 | 2017 | 123 | 123 | 100.0% | |
| STIA007 | 2018 | 119 | 123 | 96.7% | |
| STIA007 | 2020 | 128 | 130 | 98.5% | |
| STIA007 | 2021 | 128 | 141 | 90.8% | |
| STIA007 | 2022 | 134 | 141 | 95.0% | |
| STIA007 | 2023 | 139 | 142 | 97.9% |
